CClinicalTrials.gg
CompletedNCT01100697Updated May 3, 2018

Outcome of Fetal Spina Bifida

An observational study in Pregnancy and Fetal and Neonatal Health, sponsored by University of Luebeck. Completed at 1 site in Germany. Open to participants aged 12 Weeks to 12 Years. Per ClinicalTrials.gov, last updated 2018-05-03.

Sponsored by University of Luebeck · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
103
Ages
12 Weeks to 12 Years
Sex
All
01

Study summary

Neural tube defects are one of the most prevalent congenital abnormalities, surpassed only by cardiac malformations. Spina bifida accounts for the majority of the neural tube defects and is comprised of a wide spectrum of anomalies ranging from small isolated sacral dysraphisms to large spinal defects. The origin of spina bifida is a failure of neurulation. It usually occurs at 15 days post-conception, resulting in a bony spinal defect with extrusion of the neural placode and/or the meninges outside of the spinal canal. Spina bifida has a prevalence of 1-5 in 1,000 live births and is the most complex congenital abnormality compatible to long-time survival. Concerning psychomotor development as well as urinary bladder and intestinal morbidity the prognosis ranges from normal functional outcome to severe disability.

The diagnosis of serious fetal abnormalities such as spinal dysraphism by ultrasound screening allows patients to prepare for the birth of an impaired child or to consider termination of the pregnancy. In current practice, prenatal counseling and obstetric management depend not only on the detection of a spinal dysraphism but also on an appropriate assessment of the severity of the defect and its possible impact on the postnatal development of the affected child.

Level and type of lesion, presence of associated anomalies (e.g., Chiari II malformation and ventriculomegaly) and mode of surgical closure are factors known to have prognostic impact on the postnatal outcome. Previous studies reported that postnatally determined lesion levels correlated well with functional status and survival. On the contrary, it is still not clear whether similar data obtained antenatally are of value.

In this study, the investigators will review their database of all cases of prenatally diagnosed spina bifida within a 16 year period between 1993 and 2009. By analyzing the prenatal and postnatal characteristics of fetuses with spina bifida in relation to the anatomic level of the lesion, the investigators aim to contribute further information regarding the natural course of affected pregnancies and the correlation of prenatal ultrasound findings with their functional outcome.

02

Conditions studied

  • Pregnancy
  • Fetal and Neonatal Health

Browse trials for

Keywords

  • prenatal diagnosis
  • ultrasound
  • outcome
  • spina bifida
  • neural tube defect
03

In context

Spinal Dysraphism

152 studies on the registry are indexed under Spinal Dysraphism; 37 are open to participants now.

This study's enrollment of 103 is above the median of 91 across 54 observational studies indexed under Spinal Dysraphism.

Browse Spinal Dysraphism studies →

Lead sponsor

University of Luebeck is the lead sponsor of 74 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Weeks to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Fetuses with spina bifida identified at prenatal ultrasound examination between 1993 and 2009

Inclusion criteria

  • spina bifida identified at prenatal ultrasound examination
  • ultrasound diagnosis between 1993 - 2009

Exclusion criteria

Exclusion Criteria:

  • deviant postnatal diagnosis
  • loss to follow-up
  • incomplete data
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
103 participants (actual)

Groups and cohorts

  • thoracal lesion

    spinal lesion at thoracal level detected at prenatal ultrasound exam

  • lumbar lesion

    spinal lesion at lumbar level detected at prenatal ultrasound exam

  • sacral lesion

    spinal lesion at sacral level detected at prenatal ultrasound exam

06

What researchers measure

Primary outcomes

  1. pregnancy outcome

    To investigate the prenatal course and functional outcome of fetuses with spina bifida according to prenatal ultrasound exam.

    Time frame: 17 yrs

  2. Infant psychomotor development

    Kaufmann ABC Denver Developmental Screening Test walking ability muscle strenght

    Time frame: 17 yrs

  3. Infant bladder and bowel function

    Degree of continence.

    Time frame: 17 yrs

Secondary outcomes

  1. Conception date

    Time frame: 17 yrs

  2. spectrum of ultrasound signs

    Time frame: 17yrs

07

Study locations

1 site
  • Schleswig- Holstein University, Campus Lübeck, Department of Prenatal Medicine
    Lübeck, Schleswig- Holstein D- 23538, Germany
08

References and documents

Publications

  • Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009 Apr;29(4):402-11. doi: 10.1002/pd.2250. PubMed 19301349 ↗
  • D'Addario V, Rossi AC, Pinto V, Pintucci A, Di Cagno L. Comparison of six sonographic signs in the prenatal diagnosis of spina bifida. J Perinat Med. 2008;36(4):330-4. doi: 10.1515/JPM.2008.052. PubMed 18598123 ↗
  • Biggio JR Jr, Owen J, Wenstrom KD, Oakes WJ. Can prenatal ultrasound findings predict ambulatory status in fetuses with open spina bifida? Am J Obstet Gynecol. 2001 Nov;185(5):1016-20. doi: 10.1067/mob.2001.117676. PubMed 11717624 ↗
  • Peralta CF, Bunduki V, Plese JP, Figueiredo EG, Miguelez J, Zugaib M. Association between prenatal sonographic findings and post-natal outcomes in 30 cases of isolated spina bifida aperta. Prenat Diagn. 2003 Apr;23(4):311-4. doi: 10.1002/pd.584. PubMed 12673636 ↗
  • Beyer DA, Diedrich K, Weichert J, Kavallaris A, Amari F. Seasonality of spina bifida in Northern Germany. Arch Gynecol Obstet. 2011 Oct;284(4):849-54. doi: 10.1007/s00404-010-1762-0. Epub 2010 Nov 16. PubMed 21079979 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 3, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01100697
Lead sponsor
University of Luebeck
Responsible party
Daniel Alexander Beyer (Dr. D. A. Beyer, University of Luebeck) — Principal investigator
First posted
Apr 9, 2010
Start date
Dec 2009
Primary completion
Oct 2014
Completion
Oct 1, 2015
Last update
May 3, 2018

Study contacts

Feriel Amari, M.D.
principal investigator · Schleswig- Holstein University, Lübeck
Jan Weichert, M.D.
study director · Schleswig- Holstein University, Lübeck
Klaus Diedrich, PhD
study chair · Schleswig- Holstein University, Lübeck

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion